John Hamlet

John Hamlet is an accomplished executive with extensive experience in the pharmaceutical and clinical research sectors. Currently serving as the Executive Director at Thermo Fisher Scientific since April 2021, John leads the Neuroscience Pain and Movement Indication Pillars. Prior to this role, John spent nearly 30 years at PPD, where positions ranged from Senior Director Project Management to Clinical Research Associate, focusing on pain indications and overseeing clinical trials. John holds a Master’s degree in Business Administration from St. Edward's University and a Bachelor of Arts in History from The University of Texas at Austin.